News Detail
Mumbai, 3 Jan 2025: Mankind Pharma and Innovent Biologics have announced a partnership to exclusively license and commercialise sintilimab, an advanced PD-1 immunotherapy, in the Indian market. This strategic collaboration aims to address the critical challenges in cancer treatme......
View Details
Source : Express Pharma
Related News
- Complaints filed with FDA and CMO against Solapur Ayush manufacturer; owner refutes allegations (05-01-2025)
- MP FDA forms joint team with Centre to ensure revised Schedule M compliance in pharma cos (05-01-2025)
- Draft notification for extension of Schedule M published for comments (04-01-2025)
- Illegal medical shop busted in Hyderabad (04-01-2025)
- Rajasthan: Registration of psychiatric hospitals, doctors will be mandatory (04-01-2025)
- TSMC serves notice to Rushcare Hospitals for its alleged association with quacks (04-01-2025)
- Pharma teachers faking profiles at multiple institutions, face being blacklisted (04-01-2025)
- DCA officials seize falsely manufactured Calcium tablets worth Rs 1.5 lakh (04-01-2025)
- Cancer drugs present strongest innovation pipeline in next 5 years: Report (04-01-2025)
- US FDA Releases Draft Guidance on Sampling and Testing of In-Process Materials and Drug Products (04-01-2025)